5 Questions to Ask When Evaluating an Automated Life Insurance Underwriting System for Your Business
Several systems are available in the market. To help you research beyond a provider’s high-level content and demos to evaluate the right system for your business, we recommend asking them the following five questions.
Demystifying Risk Stratification of Pulmonary and Thyroid Nodules
Underwriting pulmonary and thyroid nodules has always been a distinct challenge. In a two-part article for ReFlections, RGA's Sandeepan Basu seeks to simplify the underwriting challenges associated with both types of nodules by identifying factors to better quantify risks and provide guidance.
How Data Science Is Redefining the Medical Director’s Role
Data analytics projects have become increasingly common across the insurance industry in the last few years and have really taken off in the Life sector. It’s a trend that requires the input of Medical Directors - and it gives the Directors a chance to shine.
Rapid advances in medical science’s understanding of the human genome have led to the recent development of novel gene-based therapeutic strategies. In ReFlections, RGA's Dr. Dan Zimmerman defines gene and cell therapies and provides insights into these rapidly developing and impactful technologies.
Hypothyroidism is estimated to be present in over one percent of the population and up to five percent over the age of 60. While hypothyroidism is easily diagnosable through laboratory testing, most lab panels do not include it as a routine test.
The global burden of gestational diabetes mellitus (GDM) is on the rise alongside increases in obesity and changing lifestyles. In ReFlections, RGA's Dr. Reema Nathwani Jani explores the history, complications, management, and long-term outcomes of GDM on maternal morbidity and fetal mortality, as well as links with diabetes, CVD, and cancer risks.
Have you noticed that the word invasive is being bandied about more and more often in underwriting-related articles and commentaries published online and in various industry publications? This is mainly being done by those advocating radical changes in underwriting practices.
The purpose of this paper is to discuss the insurability implications of low normal/ below normal ALT in the elderly… in the hope that insurers will consider adding appropriate guidelines for this finding at older ages.